| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/02/1994 | EP0294391B1 Process and composition for oral hygiene |
| 02/02/1994 | CN1081446A 氨基酸衍生物 Amino acid derivatives |
| 02/02/1994 | CN1081442A Benzodiazepines |
| 02/02/1994 | CN1081438A Imidazole derivatives, their method of preparation and their application in therapeutic |
| 02/02/1994 | CN1081437A Anti-ulcer pyridyloxy derivatives, their preparation and uses |
| 02/02/1994 | CN1081366A Antibacterial antiplaque oral composition |
| 02/02/1994 | CN1081365A Method for pren. of fluorodine acid injection liquid |
| 02/02/1994 | CN1081364A Preparation of inhibitor for inhibiting growth of cancer cells in animal and humen bodies |
| 02/02/1994 | CN1023646C Saccharide derivatives of protocatechualdehyde and the prepn. method |
| 02/02/1994 | CN1023645C Novel resolution process for racemic spiro hydantoins |
| 02/02/1994 | CN1023644C Antiarrhythmic drugs and the prepn. method |
| 02/01/1994 | USH1286 Administering an anticholesterol agents which is an enzyme inhibitor of angiotensin converting enzyme or/and squalene synthetase |
| 02/01/1994 | US5283383 Antitumor compound, compositions and method of use |
| 02/01/1994 | US5283361 N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as lipoxygenase inhibitors |
| 02/01/1994 | US5283343 Melatonin antagonists |
| 02/01/1994 | US5283331 Viricides |
| 02/01/1994 | US5283328 Free radical scavengers, antioxidants; treating diseases connected to aging |
| 02/01/1994 | US5283271 3,5-diphenyl or substituted 3,5-diphenyl-1-hydroxy-1,2-dihydroimidazole-2-thiones |
| 02/01/1994 | US5283268 Compounds for the treatment of inflammation and allergy |
| 02/01/1994 | US5283263 Method for treating certain psychiatric disorders and certain psychiatric symptoms |
| 02/01/1994 | US5283261 Administering orally or topically; inhibits denaturation of protein and development of opacity in lens of the eye |
| 02/01/1994 | US5283260 Method for reducing insulin resistance in mammals |
| 02/01/1994 | US5283257 Mycophenolic acid |
| 02/01/1994 | US5283254 2-(imidazol-1-yl)-2-benzylethyldiene-aminoxyalkanoic acid derivatives |
| 02/01/1994 | US5283253 Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| 02/01/1994 | US5283252 Enzyme inhibitors in the context of arachidonic acid metabolism |
| 02/01/1994 | US5283250 Renin inhibitor;hypotensive agent |
| 02/01/1994 | US5283246 Trimetazidine compounds |
| 02/01/1994 | US5283245 Antiinflammatory agent, antiallergens |
| 02/01/1994 | US5283244 Anticonvulsants, nervous system disorders |
| 02/01/1994 | US5283243 Anti-inflammatory, anti-allergic, hypotensive and vasodilating agents |
| 02/01/1994 | US5283241 Animal growth regulators |
| 02/01/1994 | US5283240 Administering prostaglandin antagonists |
| 02/01/1994 | US5283239 Inhibitor of herpesvirus absorption |
| 02/01/1994 | US5283067 Freeze drying |
| 02/01/1994 | US5283057 Risedronate in oral compositions |
| 02/01/1994 | US5282971 Cationic polymers having quaternary ammonium group covalently bonded to membrane surface as graft copolymers; permselectivity |
| 02/01/1994 | CA2101502A1 Triazolylthiomethylthio cephalosporin hydrochloride, its crystalline hydrate and the production of the same |
| 02/01/1994 | CA2101311A1 Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles |
| 02/01/1994 | CA2100197A1 Use of polysaccharides in acute peripheral neuropathies |
| 02/01/1994 | CA2075107A1 Pharmaceutical composition of dihydropyridine with neuroleptic |
| 02/01/1994 | CA1326680C N-acyl-n-naphthoylglycines as aldose reductase inhibitors |
| 02/01/1994 | CA1326675C Trienic derivatives with a chromenic structure, their processes of preparation and pharmaceutical compositions containing them |
| 02/01/1994 | CA1326674C Heteroarotinoid derivatives, their processes of preparation and pharmaceutical compositions containing them |
| 02/01/1994 | CA1326672C Dihydropyridines |
| 02/01/1994 | CA1326670C Fused 2,3-dihydroxypyrazines their preparation and use |
| 02/01/1994 | CA1326668C Ethers and thioethers having therapeutical activity, their preparation and pharmaceutical compositions containing them |
| 02/01/1994 | CA1326633C Treatment of aged skin with oral 13-cis-retinoic acid |
| 02/01/1994 | CA1326632C Long-active drug formulations comprising galanthamine for treatment of alzheimer's disease |
| 01/31/1994 | CA2141404A1 Combinations of an organic nitrate and a salicylate |
| 01/31/1994 | CA2101581A1 1-aminoacetamidopyrroles and 1-amino acetamido-2-(substituted) pyrroles and related compounds |
| 01/31/1994 | CA2101482A1 Antirheumatic composition |
| 01/31/1994 | CA2101219A1 4-substituted 1,2,4-triazole derivatives |
| 01/31/1994 | CA2100600A1 New carbohydrate-based anti-inflammatory agents |
| 01/28/1994 | CA2481077A1 Beta-alethine use in cell culture and therapy |
| 01/28/1994 | CA2101197A1 Pradimicins t1 and t2 and 11-o-dexylosylpradimicin t1, new members of the pradimicin family of antibiotics |
| 01/27/1994 | DE4324859A1 Oral compsn. for treating periodontal disease - contg. antibody obtd. by immunising animal with surface polysaccharide from pathogenic bacteria |
| 01/27/1994 | DE4224670A1 Verwendung von â,w-Dicarbonsäuren als Fibrinogensenker Use of beta, w-dicarboxylic acids as Fibrinogensenker |
| 01/27/1994 | DE4224402A1 Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung Last pyridine derivatives with leukotriene antagonist activity B¶4¶ |
| 01/27/1994 | DE4223940A1 Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New acyclic amidine-containing diphosphonic acid derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 01/27/1994 | DE4223921A1 Use of DOPA-decarboxylase inhibitors or dopamine receptor antagonists - to treat redn. of kidney function in humans |
| 01/26/1994 | EP0580550A1 Oxamic acid derivatives as hypocholesteremic agents |
| 01/26/1994 | EP0580541A1 New piperidine derivatives of benzimidazole as antihistanminic and antiallergic agents |
| 01/26/1994 | EP0580539A2 Amidines derived from 3-aminoethyl indoles for the treatment of migraines |
| 01/26/1994 | EP0580503A1 Aminoalkylchromones, process for their preparation and compositions containing them |
| 01/26/1994 | EP0580502A1 3-(Hydroxybenzylidenyl)-indoline-2-ones and pharmaceutical compositions containing them |
| 01/26/1994 | EP0580480A1 Pradimic acids, amides, and novel pradimicin derivatives |
| 01/26/1994 | EP0580465A1 New therapeutic use of heterocyclic piperazines as 5-HT3 agonists and new derivatives |
| 01/26/1994 | EP0580459A1 Substituted Phenylimidazolidins, process for their preparation, their use as medicaments and their pharmaceutical compositions containing them |
| 01/26/1994 | EP0580429A1 Use of competitive NMDA receptor antagonists in the treatment of urinary incontinence |
| 01/26/1994 | EP0580402A2 Aminediol protease inhibitors |
| 01/26/1994 | EP0580378A1 Substituted benzoate derivatives |
| 01/26/1994 | EP0580371A1 Monensin derivatives |
| 01/26/1994 | EP0580268A2 Ocular hypotensive agents |
| 01/26/1994 | EP0580185A1 Medicaments |
| 01/26/1994 | EP0580161A1 Prophylactic and therapeutic treatment of Alzheimer's disease |
| 01/26/1994 | EP0580079A1 Crosslinked, nitrogen-containing vinyl copolymers, process for their manufacture and use of these compounds |
| 01/26/1994 | EP0580078A1 Hydrophilic groups containing poly(vinylamine) derivatives, process for their manufacture and use thereof as pharmaceutical compounds, substrates for active substances and foodstuff ingredients |
| 01/26/1994 | EP0580074A1 Stable preparation containing azelastine hydrochloride |
| 01/26/1994 | EP0580008A2 Phenylimidazolidine Derivatives, their preparation and use |
| 01/26/1994 | EP0579996A1 Inclusion compounds of 5,10-methylenetetrahydrofolic acid and cyclodextrin |
| 01/26/1994 | EP0579968A1 4-Iminoquinolines, processes for their preparation and their use |
| 01/26/1994 | EP0579939A1 Phospholipid derivatives |
| 01/26/1994 | EP0579915A1 Pharmaceutical composition containing a-cis- o 13-cis-retinoic acid or acitretin and a vitamin D derivative |
| 01/26/1994 | EP0579901A1 Use of a feed additive for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation |
| 01/26/1994 | EP0579827A1 Method of preparing 2-arylbenzimidazole 5-sulphonic acids |
| 01/26/1994 | EP0579826A1 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics |
| 01/26/1994 | EP0579819A1 Novel pyridone derivatives, preparation method therefor, novel intermediates thereby obtained, their use as drugs, and pharmaceutical compositions containing same |
| 01/26/1994 | EP0579806A1 Medicament for the treatment and/or prophylaxis of folate metabolism disorders |
| 01/26/1994 | EP0579791A1 Cellular composition for the treatment of human or animal organisms |
| 01/26/1994 | EP0579784A1 Method for preventing restenosis following reconfiguration of body vessels |
| 01/26/1994 | EP0579782A1 Method for assaying ionized magnesium and calcium concentrations and a composition of bioavailable magnesium and calcium |
| 01/26/1994 | EP0579769A1 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2(5h)-furanones as anti-inflammatory agents |
| 01/26/1994 | EP0579766A1 N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders |
| 01/26/1994 | EP0579760A1 Method of treatment using steroid mouthwash |
| 01/26/1994 | EP0579754A1 Use of amines to sensitize multidrug-resistant cells |
| 01/26/1994 | EP0579733A1 Thiazolidinedione derivatives, production and use thereof |
| 01/26/1994 | EP0579731A1 Disubstituted naphthalenes |
| 01/26/1994 | EP0579695A1 Reissert compounds as anti-hiv agents |
| 01/26/1994 | EP0579681A1 Crystalline tiagabine hydrochloride monohydrate, its preparation and use |